News
Get the RSS
Category:
Investment
- Corundum Systems Biology Invests in a Biotech Company Specializing in Improved Reproductive Health for Women
- GrayMatters Health was granted approval for marketing its technology by the Ministry of Health in Israel
- Joy Ventures Rebrands as Corundum Neuroscience, Launching New Venture Builder and Fund to Spur Neuroscience Technology Innovation
- Corundum Systems Biology Invests in a Biotech Firm Focused on Skin Health
- U.S. FDA Grants GrayMatters Health 510(k) Clearance to Market Prism for PTSD
- Corundum Systems Biology Participates in Concerto Biosciences Series A Financing Round raising $23 million
- Theranica, a Corundum’s portfolio, raised $45 million in its Series C financing round
- Initial Closing of Corundum’s Second Israeli VC Fund, and Start of Consulting Service for New Business Development